1. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway
   Tang Bufu et al, 2018, Anti-Cancer Drugs CrossRef
2. Molecular targets of celastrol in cancer: Recent trends and advancements
   Dharambir Kashyap et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
3. Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages
   Yuening Yang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
4. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells
   Xiaojing Li et al, 2018, European Journal of Pharmacology CrossRef
5. Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway
   Ming-Ju Hsieh et al, 2018, Phytomedicine CrossRef
6. CD100-Plexin-B1 induces Epithelial-Mesenchymal Transition of head and neck squamous cell carcinoma and promotes metastasis
   Chen Zhang et al, 2019, Cancer Letters CrossRef
7. Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.
   Xinqiang Song et al, 2019, Int Immunopharmacol CrossRef
8. Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells.
   Shihao Du et al, 2020, Sci Rep CrossRef
9. Protective effects of celastrol against γ irradiation‑induced oxidative stress in human umbilical vein endothelial cells
   Xiang‑Bei Han et al, 2018, Exp Ther Med CrossRef
10. The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells
    Huihui Li et al, 2018, Oncol Lett CrossRef
11. Nuclear factor-κB plays an important role in Tamarixetin-mediated inhibition of matrix metalloproteinase-9 expression
    Sanu K. Shaji et al, 2020, European Journal of Pharmacology CrossRef
12. Matrix Metalloproteinases (MMPs) and Diabetic Foot: Pathophysiological Findings and Recent Developments in Their Inhibitors of Natural as well as Synthetic Origin
    Kirandeep Kaur et al, 2020 CrossRef
13. Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and In Vitro Experiments
    Xuan Wang et al, 2022, Front. Pharmacol. CrossRef
14. The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
    Saabira Banu Sahubar Sadik et al, 2022 CrossRef
15. Antioxidant, Wound Healing Potential and In Silico Assessment of Naringin, Eicosane and Octacosane
    Abbirami Balachandran et al, 2023, Molecules CrossRef
16. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis
    Wei Peng et al, 2023 CrossRef
17. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
    Cheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
18. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach
    Bahar Kartal et al, 2024, Med Oncol CrossRef
19. Celastrol Mediates CAV1 to Attenuate Pro-tumorigenic Effects of Senescent Cells
    Shuo Zhang et al, 2024, Phytomedicine CrossRef
20. The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer
    Kang Wu et al, 2024, Toxicology and Applied Pharmacology CrossRef
21. Effects of curcumin nanoparticles on the proliferation and migration of human ovarian cancer cells assessed through the NF-κB/PRL-3 signaling pathway
    Shuyan Liu et al, 2024, International Immunopharmacology CrossRef